AYYAN Investment Co. (2140) is listed on Tadawul under the Health Care Equipment & Svc sector. In fiscal year 2025, the company reported revenue of SAR 9M, net profit of SAR -9M, and earnings per share of SAR 3.57. The stock trades at a P/E ratio of 2.4. All figures sourced from the official CMA-mandated XBRL filing dated 2025-12-31.
AYYAN Investment Co. (2140) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).
For fiscal year 2025, AYYAN Investment Co. reported revenue of SAR 9M, net profit of SAR -9M, and earnings per share of SAR 3.57. Total assets stood at SAR 1.04B with total equity of SAR 952M and total liabilities of SAR 89M.
Operating cash flow for 2025 was SAR -238M. Free cash flow was SAR -36M.
Revenue growth from 2024 to 2025: -43.7%. Net profit growth over the same period: -74.9%. 3-year revenue CAGR: -67.3%.
Key financial ratios for 2025: Return on Equity -1.0%, Return on Assets -0.9%, Net Margin -107.7%, Debt to Equity 0.09.
In 2024, AYYAN Investment Co. reported revenue of SAR 15M and net profit of SAR -5M, compared to SAR 9M and SAR -9M respectively in 2025.
Loading...